{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:41:53Z","timestamp":1790797313945,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphangioleiomyomatosis (LAM) is a multisystem disease of women, affecting lungs, kidneys, and lymphatics. It is caused by the proliferation of abnormal smooth muscle\u2013like LAM cells, with mutations and loss of heterozygosity in the TSC1 or, more frequently, TSC2 genes. Isolated pulmonary LAM cells have been difficult to maintain in culture, and most studies of LAM lung cells involve mixtures of TSC2 wild-type and TSC2-null cells. A clonal population of LAM lung cells has not been established, making analysis of the cells challenging. Cell lines have been established from angiomyolipomas, a common manifestation of LAM, and from tumors from patients with TSC. Circulating LAM cells have also been isolated from blood and other body fluids. LAM cells may also be identified in clusters apparently derived from lymphatic vessels. Genetics, patterns of antigen expression, and signaling pathways have been studied in LAM lung tissue and in LAM cell models, although rarely all in the same study. We show here that LAM cells manifest differences in these characteristics, depending on the source investigated, suggesting further studies.<\/jats:p>","DOI":"10.1165\/rcmb.2017-0403tr","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T14:49:42Z","timestamp":1517928582000},"page":"678-683","source":"Crossref","is-referenced-by-count":21,"title":["The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models"],"prefix":"10.1093","volume":"58","author":[{"given":"Wendy K.","family":"Steagall","sequence":"first","affiliation":[{"name":"Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Pacheco-Rodriguez","sequence":"additional","affiliation":[{"name":"Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Darling","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Torre","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[{"name":"Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"2026012222030654300_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","article-title":"Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis","volume":"21","author":"Matsumoto","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222030654300_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.2212001448","article-title":"Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas","volume":"221","author":"Avila","year":"2001","journal-title":"Radiology"},{"key":"2026012222030654300_bib3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib4","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222030654300_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1513\/pats.200705-061VS","article-title":"Smooth muscle\u2013like cells in pulmonary lymphangioleiomyomatosis","volume":"5","author":"Krymskaya","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"2026012222030654300_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012222030654300_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-med-050715-104245","article-title":"Lymphangioleiomyomatosis: a monogenic model of malignancy","volume":"68","author":"Krymskaya","year":"2017","journal-title":"Annu Rev Med"},{"key":"2026012222030654300_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2017.01.033","article-title":"Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical trial","volume":"151","author":"El-Chemaly","year":"2017","journal-title":"Chest"},{"key":"2026012222030654300_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/lrb.2009.0013","article-title":"Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC)","volume":"8","author":"Kwiatkowski","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2026012222030654300_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"key":"2026012222030654300_bib11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1164\/ajrccm.164.8.2104095","article-title":"Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis","volume":"164","author":"Yu","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/lrb.2009.0024","article-title":"The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis","volume":"8","author":"Taveira-DaSilva","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2026012222030654300_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222030654300_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.187.6.663","article-title":"Exonic mutations of TSC2\/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis","volume":"187","author":"Badri","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.5858\/2009-0576-RS.1","article-title":"Pulmonary lymphangioleiomyomatosis","volume":"134","author":"Zhang","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2026012222030654300_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1369\/0022155413489311","article-title":"Lymphatic endothelial differentiation in pulmonary lymphangioleiomyomatosis cells","volume":"61","author":"Davis","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"2026012222030654300_bib17","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.5858\/2000-124-1642-HOTIPI","article-title":"Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"2026012222030654300_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/09059180.00009311","article-title":"Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis","volume":"21","author":"Glasgow","year":"2012","journal-title":"Eur Respir Rev"},{"key":"2026012222030654300_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2005-0387OC","article-title":"Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis","volume":"35","author":"Valencia","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222030654300_bib20","doi-asserted-by":"crossref","first-page":"e0126025","DOI":"10.1371\/journal.pone.0126025","article-title":"Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis","volume":"10","author":"Clements","year":"2015","journal-title":"PLoS One"},{"key":"2026012222030654300_bib21","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/0008-5472.CAN-06-1122","article-title":"Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis","volume":"67","author":"D\u2019Armiento","year":"2007","journal-title":"Cancer Res"},{"key":"2026012222030654300_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9440(10)63843-6","article-title":"Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures","volume":"162","author":"Karbowniczek","year":"2003","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.pas.0000126859.70814.6d","article-title":"Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis","volume":"28","author":"Kumasaka","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2026012222030654300_bib24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/01.pas.0000172192.25295.45","article-title":"Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis","volume":"29","author":"Kumasaka","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2026012222030654300_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1378\/chest.08-1160","article-title":"Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement","volume":"135","author":"Glasgow","year":"2009","journal-title":"Chest"},{"key":"2026012222030654300_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJMc0707517","article-title":"Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis","volume":"358","author":"Young","year":"2008","journal-title":"N Engl J Med"},{"key":"2026012222030654300_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ajpath.2013.05.024","article-title":"Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene","volume":"183","author":"Steagall","year":"2013","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib28","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-17-0925","article-title":"Human pluripotent stem cell\u2013derived TSC2-haploinsufficient smooth muscle cells recapitulate features of lymphangioleiomyomatosis","volume":"77","author":"Julian","year":"2017","journal-title":"Cancer Res"},{"key":"2026012222030654300_bib29","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222030654300_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2026012222030654300_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20131080","article-title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells","volume":"211","author":"Li","year":"2014","journal-title":"J Exp Med"},{"key":"2026012222030654300_bib32","doi-asserted-by":"crossref","first-page":"e86629","DOI":"10.1172\/jci.insight.86629","article-title":"Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis","volume":"1","author":"Li","year":"2016","journal-title":"JCI Insight"},{"key":"2026012222030654300_bib33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ajpath.2017.04.014","article-title":"Cathepsin K in lymphangioleiomyomatosis: LAM cell\u2013fibroblast interactions enhance protease activity by extracellular acidification","volume":"187","author":"Dongre","year":"2017","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib34","doi-asserted-by":"crossref","first-page":"F831","DOI":"10.1152\/ajprenal.00441.2011","article-title":"Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress","volume":"303","author":"Siroky","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026012222030654300_bib35","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ajpath.2016.03.009","article-title":"evidence supporting a lymphatic endothelium origin for angiomyolipoma, a TSC2(\u2212) tumor related to lymphangioleiomyomatosis","volume":"186","author":"Yue","year":"2016","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle\u2013like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor","volume":"167","author":"Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib37","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2353\/ajpath.2009.080799","article-title":"The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells","volume":"174","author":"Lesma","year":"2009","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"2026012222030654300_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2014.938","article-title":"Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements","volume":"150","author":"Teng","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2026012222030654300_bib40","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","article-title":"Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex","volume":"23","author":"Tyburczy","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2026012222030654300_bib41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201003-0489OC","article-title":"Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis","volume":"182","author":"Cai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.20042469","article-title":"MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development","volume":"202","author":"Li","year":"2005","journal-title":"J Exp Med"},{"key":"2026012222030654300_bib43","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","article-title":"Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene","volume":"182","author":"Pacheco-Rodriguez","year":"2009","journal-title":"J Immunol"},{"key":"2026012222030654300_bib44","doi-asserted-by":"crossref","first-page":"L64","DOI":"10.1152\/ajplung.00095.2010","article-title":"Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2","volume":"300","author":"Ikeda","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222030654300_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ncomms1236","article-title":"Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis","volume":"2","author":"Li","year":"2011","journal-title":"Nat Commun"},{"key":"2026012222030654300_bib46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaad.2015.07.018","article-title":"Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus","volume":"73","author":"Nathan","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026012222030654300_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2016.3545","article-title":"Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex: a randomized clinical trial","volume":"153","author":"Wataya-Kaneda","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2026012222030654300_bib48","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222030654300_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1378\/chest.13-1071","article-title":"Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis","volume":"145","author":"Cai","year":"2014","journal-title":"Chest"},{"key":"2026012222030654300_bib50","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.chest.2016.02.654","article-title":"Sirolimus therapy for patients with lymphangioleiomyomatosis leads to loss of chylous ascites and circulating LAM cells","volume":"150","author":"Harari","year":"2016","journal-title":"Chest"},{"key":"2026012222030654300_bib51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201412-2170LE","article-title":"Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation","volume":"191","author":"Steagall","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/rccm.201408-1480LE","article-title":"Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer","volume":"191","author":"Zhang","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib53","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","article-title":"Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study","volume":"161","author":"Matsui","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib54","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2007-1283","article-title":"Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase\u2013induced cell invasiveness","volume":"93","author":"Glassberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026012222030654300_bib55","first-page":"3353","article-title":"Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis","volume":"35","author":"Grzegorek","year":"2015","journal-title":"Anticancer Res"},{"key":"2026012222030654300_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-014-1559-9","article-title":"In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor","volume":"464","author":"Gao","year":"2014","journal-title":"Virchows Arch"},{"key":"2026012222030654300_bib57","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1158\/0008-5472.CAN-07-1356","article-title":"TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis","volume":"67","author":"Pacheco-Rodriguez","year":"2007","journal-title":"Cancer Res"},{"key":"2026012222030654300_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.200911-1737OC","article-title":"Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis","volume":"182","author":"Terasaki","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012222030654300_bib59","doi-asserted-by":"crossref","first-page":"L899","DOI":"10.1152\/ajplung.00365.2015","article-title":"Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis","volume":"310","author":"Ando","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012222030654300_bib60","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.4049\/jimmunol.0902149","article-title":"Role of the CXCR4\/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma","volume":"185","author":"Clements","year":"2010","journal-title":"J Immunol"},{"key":"2026012222030654300_bib61","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"2026012222030654300_bib62","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AJCPPC9EX1ZHMRMA","article-title":"\u03b2-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis","volume":"135","author":"Flavin","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"2026012222030654300_bib63","doi-asserted-by":"crossref","first-page":"pii: e23202","DOI":"10.7554\/eLife.23202","article-title":"Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3","volume":"6","author":"Klover","year":"2017","journal-title":"eLife"},{"key":"2026012222030654300_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"key":"2026012222030654300_bib65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2310\/6650.2001.33787","article-title":"Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis","volume":"49","author":"Valencia","year":"2001","journal-title":"J Investig Med"},{"key":"2026012222030654300_bib66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2353\/ajpath.2009.080830","article-title":"Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium","volume":"175","author":"Issaka","year":"2009","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib67","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2353\/ajpath.2009.090525","article-title":"Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells","volume":"175","author":"Klarquist","year":"2009","journal-title":"Am J Pathol"},{"key":"2026012222030654300_bib68","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/PAS.0b013e318235edbd","article-title":"Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients","volume":"35","author":"Hayashi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"2026012222030654300_bib69","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/hupa.2000.18500","article-title":"Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases","volume":"31","author":"Matsui","year":"2000","journal-title":"Hum Pathol"},{"key":"2026012222030654300_bib70","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"2026012222030654300_bib71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1165\/rcmb.2005-0300OC","article-title":"Abnormal growth of smooth muscle\u2013like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012222030654300_bib72","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/modpathol.3800610","article-title":"Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas","volume":"19","author":"Robb","year":"2006","journal-title":"Mod Pathol"},{"key":"2026012222030654300_bib73","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026012222030654300_bib74","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal\u2013epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012222030654300_bib75","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/0008-5472.CAN-16-2755","article-title":"Aberrant SYK kinase signaling is essential for tumorigenesis induced by TSC2 inactivation","volume":"77","author":"Cui","year":"2017","journal-title":"Cancer Res"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/6\/678\/66467146\/ajrcmb_58_6_678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/58\/6\/678\/66467146\/ajrcmb_58_6_678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:03:42Z","timestamp":1769137422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/58\/6\/678\/8430606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,1]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2017-0403tr","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,6,1]]}}}